470 related articles for article (PubMed ID: 22801037)
1. Targeting the sphingosine kinase/sphingosine 1-phosphate pathway in disease: review of sphingosine kinase inhibitors.
Orr Gandy KA; Obeid LM
Biochim Biophys Acta; 2013 Jan; 1831(1):157-66. PubMed ID: 22801037
[TBL] [Abstract][Full Text] [Related]
2. Sphingosine kinase/sphingosine 1-phosphate signaling in cancer therapeutics and drug resistance.
Selvam SP; Ogretmen B
Handb Exp Pharmacol; 2013; (216):3-27. PubMed ID: 23563649
[TBL] [Abstract][Full Text] [Related]
3. Targeting sphingosine-1-phosphate signaling in lung diseases.
Ebenezer DL; Fu P; Natarajan V
Pharmacol Ther; 2016 Dec; 168():143-157. PubMed ID: 27621206
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the sphingosine kinase/sphingosine 1-phosphate pathway.
Gandy KA; Obeid LM
Handb Exp Pharmacol; 2013; (216):275-303. PubMed ID: 23563662
[TBL] [Abstract][Full Text] [Related]
5. Sphingosine kinase 1 as an anticancer therapeutic target.
Gao Y; Gao F; Chen K; Tian ML; Zhao DL
Drug Des Devel Ther; 2015; 9():3239-45. PubMed ID: 26150697
[TBL] [Abstract][Full Text] [Related]
6. Sphingosine-1-phosphate signaling and its role in disease.
Maceyka M; Harikumar KB; Milstien S; Spiegel S
Trends Cell Biol; 2012 Jan; 22(1):50-60. PubMed ID: 22001186
[TBL] [Abstract][Full Text] [Related]
7. Development of small-molecule inhibitors of sphingosine-1-phosphate signaling.
Edmonds Y; Milstien S; Spiegel S
Pharmacol Ther; 2011 Dec; 132(3):352-60. PubMed ID: 21906625
[TBL] [Abstract][Full Text] [Related]
8. Sphingosine kinase and sphingosine-1-phosphate regulate epithelial cell architecture by the modulation of de novo sphingolipid synthesis.
Santacreu BJ; Pescio LG; Romero DJ; Corradi GR; Sterin-Speziale N; Favale NO
PLoS One; 2019; 14(3):e0213917. PubMed ID: 30897151
[TBL] [Abstract][Full Text] [Related]
9. "Inside-out" signaling of sphingosine-1-phosphate: therapeutic targets.
Takabe K; Paugh SW; Milstien S; Spiegel S
Pharmacol Rev; 2008 Jun; 60(2):181-95. PubMed ID: 18552276
[TBL] [Abstract][Full Text] [Related]
10. [The drug development based on sphingosine-1-phosphate signaling pathway].
Bai J; Hu JP
Yao Xue Xue Bao; 2016 Dec; 51(12):1822-8. PubMed ID: 29908533
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic Strategies and Pharmacological Tools Influencing S1P Signaling and Metabolism.
Vogt D; Stark H
Med Res Rev; 2017 Jan; 37(1):3-51. PubMed ID: 27480072
[TBL] [Abstract][Full Text] [Related]
12. New perspectives on the role of sphingosine 1-phosphate in cancer.
Pyne S; Pyne NJ
Handb Exp Pharmacol; 2013; (216):55-71. PubMed ID: 23563651
[TBL] [Abstract][Full Text] [Related]
13. Sphingosine kinase signalling in immune cells: potential as novel therapeutic targets.
Melendez AJ
Biochim Biophys Acta; 2008 Jan; 1784(1):66-75. PubMed ID: 17913601
[TBL] [Abstract][Full Text] [Related]
14. Autocrine and paracrine roles of sphingosine-1-phosphate.
Alvarez SE; Milstien S; Spiegel S
Trends Endocrinol Metab; 2007 Oct; 18(8):300-7. PubMed ID: 17904858
[TBL] [Abstract][Full Text] [Related]
15. Sphingosine kinase and sphingosine 1-phosphate in the heart: a decade of progress.
Karliner JS
Biochim Biophys Acta; 2013 Jan; 1831(1):203-12. PubMed ID: 22735359
[TBL] [Abstract][Full Text] [Related]
16. The Tumorigenic Effect of Sphingosine Kinase 1 and Its Potential Therapeutic Target.
Wang X; Sun Y; Peng X; Naqvi SMAS; Yang Y; Zhang J; Chen M; Chen Y; Chen H; Yan H; Wei G; Hong P; Lu Y
Cancer Control; 2020; 27(1):1073274820976664. PubMed ID: 33317322
[TBL] [Abstract][Full Text] [Related]
17. Sphingosine 1-phosphate and sphingosine kinases in health and disease: Recent advances.
Pyne S; Adams DR; Pyne NJ
Prog Lipid Res; 2016 Apr; 62():93-106. PubMed ID: 26970273
[TBL] [Abstract][Full Text] [Related]
18. Sphingosine-1-phosphate: the Swiss army knife of sphingolipid signaling.
Maceyka M; Milstien S; Spiegel S
J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S272-6. PubMed ID: 18987387
[TBL] [Abstract][Full Text] [Related]
19. Sphingosine-1-phosphate and immune regulation: trafficking and beyond.
Chi H
Trends Pharmacol Sci; 2011 Jan; 32(1):16-24. PubMed ID: 21159389
[TBL] [Abstract][Full Text] [Related]
20. Targeting the sphingosine kinase/sphingosine 1-phosphate pathway to treat chronic inflammatory kidney diseases.
Schwalm S; Pfeilschifter J; Huwiler A
Basic Clin Pharmacol Toxicol; 2014 Jan; 114(1):44-9. PubMed ID: 23789924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]